-
1دورية أكاديمية
المؤلفون: Peter Larsson, Maxim Olsson, Sithumini Sarathchandra, Anna Fäldt Beding, Eva Forssell-Aronsson, Anikó Kovács, Per Karlsson, Khalil Helou, Toshima Z. Parris
المصدر: Scientific Reports, Vol 14, Iss 1, Pp 1-20 (2024)
مصطلحات موضوعية: Drug repurposing, Proteasome inhibitor, Bortezomib, Gene expression profiling, Mutation profiling, Cancer, Medicine, Science
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-2322
-
2دورية أكاديمية
المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
مصطلحات موضوعية: Cancer, Pancancer, TCGA, BIRC5, Survivin, Gene expression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1471-2407
-
3دورية أكاديمية
المؤلفون: Nina Oparina, Malin C. Erlandsson, Anna Fäldt Beding, Toshima Parris, Khalil Helou, Per Karlsson, Zakaria Einbeigi, Maria I. Bokarewa
المصدر: Cancers, Vol 13, Iss 9, p 2209 (2021)
مصطلحات موضوعية: BIRC5, survivin, breast cancer, survival probability, molecular signature, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4
المؤلفون: N. Oparina, Malin C. Erlandsson, Per Karlsson, Zakaria Einbeigi, Maria Bokarewa, Toshima Z. Parris, Khalil Helou, Anna Fäldt Beding
المصدر: Cancers
Volume 13
Issue 9
Cancers, Vol 13, Iss 2209, p 2209 (2021)مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Estrogen receptor, survivin, Inhibitor of apoptosis, Article, Transcriptome, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, breast cancer, Histologic grade, Internal medicine, Survivin, Medicine, survival probability, RC254-282, Survival analysis, business.industry, BIRC5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, molecular signature, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, business
وصف الملف: application/pdf